Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Cephalon Plans $161M Purchase Of Australian Company SIRTeX

Feb. 13, 2003

By Aaron Lorenzo

Aradigm Raises $15M Through Private Placement Of Shares

Feb. 13, 2003

By Aaron Lorenzo

Accelrys, Confirmant Working To Produce Protein Database

Feb. 12, 2003

By Aaron Lorenzo

Johnson & Johnson Buying Scios For $2.4 Billion In Cash

Feb. 11, 2003

By Aaron Lorenzo

It's official. Scios Inc. is selling out to Johnson & Johnson in a $2.4 billion cash deal. (BioWorld Today)

Johnson & Johnson Buying Scios For $2.4 Billion In Cash

Feb. 11, 2003

By Aaron Lorenzo

It's official. Scios Inc. is selling out to Johnson & Johnson in a $2.4 billion cash deal. (BioWorld Today)

Scios Speculated To Be Subject Of $2 Billion Acquisition By J&J

Feb. 10, 2003

By Aaron Lorenzo

Scios Inc. saw its stock price surge 21.7 percent Friday on reports that it was engaged in merger talks with Johnson & Johnson - a rumored $2 billion purchase. (BioWorld Today)

IntraBiotics Pinning Hopes On Phase II/III Study Of Iseganan

Feb. 10, 2003

By Aaron Lorenzo

Scios Speculated To Be Subject Of $2 Billion Acquisition By J&J

Feb. 10, 2003

By Aaron Lorenzo

Scios Inc. saw its stock price surge 21.7 percent Friday on reports that it was engaged in merger talks with Johnson & Johnson - a rumored $2 billion purchase. (BioWorld Today)

IntraBiotics Pinning Hopes On Phase II/III Study Of Iseganan

Feb. 10, 2003

By Aaron Lorenzo

Icogen's Chemokine Research Receives $1M SBIR Award

Feb. 6, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...